# A Study of LY3832479 (LY-CoV016) in Healthy Participants 1

> **NCT04611789** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3832479
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04611789
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-02
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04611789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04611789, "A Study of LY3832479 (LY-CoV016) in Healthy Participants 1". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04611789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*